in ,

NIH Allergy Institute Taps Emergent BioSolutions for Anthrax Vaccine Dry Formulation; Adam Havey Comments

NIH Allergy Institute Taps Emergent BioSolutions for Anthrax Vaccine Dry Formulation; Adam Havey Comments - top government contractors - best government contracting event

Emergent BioSolutionsEmergent BioSolutions has landed a five-year, $29 million contract with the National Institute of Allergy and Infectious Diseases to make a dry formulation of the NuThrax anthrax vaccine candidate in an effort to facilitate shipping and storage at normal temperatures.

The company said Monday the contract covers manufacturing, non-clinical processes and application to the U.S. Food and Drug Administration for Investigational New Drug status.

“We are committed to responding to the U.S. government’s needs to combat the ongoing threat of bioterrorism,” said Adam Havey, Emergent BioSolutions executive vice president and biodefense division president.

Havey said the vaccine candidate is intended to induce higher immune response and fewer doses.

NuThrax consists of the Anthrax Vaccine Adsorbed BioThrax and CPG 7909, an immunostimulatory oligodeoxynucleotide compound.

NIAID is part of the National Institutes of Health.

IDC's Melanie Posey Outlines Considerations for Subscription-Based Software Adoption - top government contractors - best government contracting event

IDC’s Melanie Posey Outlines Considerations for Subscription-Based Software Adoption

Raytheon, Navy Complete Tomahawk Missile Flight Tests; Mike Jarrett Comments - top government contractors - best government contracting event

Raytheon, Navy Complete Tomahawk Missile Flight Tests; Mike Jarrett Comments